Latest Breaking News On - இரண்டாவது மரபணு இன்க் - Page 1 : comparemela.com

Share this article Share this article ResearchAndMarkets.com s offering. The global human microbiome therapeutics market is expected to reach a value of nearly $148.6 million in 2025, having increased at a compound annual growth rate (CAGR) of 21.9% since 2023. The market is expected to increase from $148.6 million in 2025 to $400.0 million in 2030 having increasing at growth rate of 21.9%. Growth is forecast period is expected to drive by increase in funding, increase in prevalence of chronic diseases and technological advances. Factors that could hinder the growth of the human microbiome therapeutics market in the future include ethical issues associated with the market. The human microbiome therapeutics market is segmented disease into infectious diseases, gastrointestinal disorders, metabolic disorders, cancers and other diseases. The infectious diseases market was the largest segment of the human microbiome therapeutics market segmented by disease, accounting for 70.9% of

United statesAsia pacificLaura woodEnterome bioscienceCustom researchAssembly biosciencesInvestments on development of cancer microbiome therapeuticsOffice hours callMicrobiome therapeuticsSecond genome incVithera pharmaceuticals incDrug developmentE st office hours callTechnology typeRebiotix incWestern europe